JP

Jianfeng PAN

NA Novartis Ag: 3 patents #1,476 of 5,128Top 30%
CC Chia Tai Tianqing Pharmaceutical Group Co.: 1 patents #163 of 370Top 45%
GS Glaxosmithkline Biologicals Sa: 1 patents #268 of 523Top 55%
📍 Nantong, CA: #6 of 9 inventorsTop 70%
Overall (All Time): #680,434 of 4,157,543Top 20%
7
Patents All Time

Issued Patents All Time

Showing 1–7 of 7 patents

Patent #TitleCo-InventorsDate
12281118 Nitrogen-containing fused heterocyclic SHP2 inhibitor compound, preparation method, and use Huixin Wan, Jingui Ma, Chuantao Cha 2025-04-22
11993596 Fused tri-cyclic compound as PDE3/PDE4 dual inhibitor Yunfu Luo, Guoli Zhang, Sheng-Chieh Su, Yong Wang, Shuhui CHEN 2024-05-28
11458138 6-6 fused bicyclic heteroaryl compounds and their use as LATS inhibitors Dirk Behnke, Frada BERENSHTEYN, Xueshi Hao, Timothy Z. Hoffman, Qihui Jin +11 more 2022-10-04
10098949 Adsorption of immunopotentiators to insoluble metal salts Manmohan Singh, David A. G. Skibinksi, Tom Yao-Hsiang Wu, Yongkai Li, Alex Cortez +4 more 2018-10-16
9365506 Compounds and compositions as TLR2 agonists Tom Yao-Hsiang Wu, Yefen Zou, Timothy Z. Hoffman 2016-06-14
9315530 Adsorption of immunopotentiators to insoluble metal salts Manmohan Singh, David Skibinski, Tom Yao-Hsiang Wu, Yongkai Li, Alex Cortez +4 more 2016-04-19
8808703 Compounds (cystein based lipopeptides) and compositions as TLR2 agonists used for treating infections, inflammations, respiratory diseases etc Tom Yao-Hsiang Wu, Yefen Zou, Timothy Z. Hoffman 2014-08-19